Kilitch Drugs India Q2 Results
- BSE: 524500
- NSE: KILITCH
- ISIN: INE729D01010
- Sector: Biotechnology & Drugs
BSE
306.6
-2.45 (-0.79%)
-2.45 (-0.79%)Volume895.00
Updated: Mon 25 Nov, 2024 | 15:28:12
NSE
307.45-2.60 (-0.84%)
-2.60 (-0.84%)Volume7.09 K
Updated: Mon 25 Nov, 2024 | 15:31:32
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹47.47 Cr.(41.92%)
- Operating Profit₹5.49 Cr.(579.34%)
- Profit After Tax₹8.62 Cr.(542.92%)
- Operating Margin11.56%(-38.96%)
Note: Comparison is on YoY basis
Quarterly - Kilitch Drugs India Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 47.47 | 36.56 | -% | 41.20 | -% |
| Selling/ General/ Admin Expenses Total | 2.59 | 2.52 | -% | 2.61 | -% |
| Depreciation/ Amortization | 0.60 | 0.79 | -% | 0.82 | -% |
| Other Operating Expenses Total | 8.59 | 8.16 | -% | 7.08 | -% |
| Total Operating Expense | 41.99 | 31.17 | -% | 33.40 | -% |
| Operating Income | 5.49 | 5.39 | -% | 7.80 | -% |
| Net Income Before Taxes | 10.35 | 4.45 | -% | 6.78 | -% |
| Net Income | 8.62 | 3.36 | -% | 4.74 | -% |
| Diluted Normalized EPS | 5.36 | 2.15 | -% | 2.93 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST